Pharmaceutical News

RSS

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer. The recall includes oral tablets, capsules, and syrup.

27 Nov 2019

Some antiarrhythmic medications for AFib less effective in obese patients

Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity and AFib, the underlying mechanism of how obesity contributes to the heart arrhythmia is still unknown.

27 Nov 2019

Geospatial model helps compare costs of different anticoagulant therapies

Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation. A new study from the University of Eastern Finland shows that direct oral anticoagulants can be a more cost-effective alternative than traditional warfarin therapy when the patient's place of residence is taken into consideration.

27 Nov 2019

FDA-approved anti-inflammatory drug delays onset of ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)--a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death--is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

27 Nov 2019

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

A one-off dose of ketamine could help heavy drinkers reduce their alcohol intake, finds a new UCL experimental study.

26 Nov 2019

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

The neuropeptide αCGRP (α calcitonin gene-related peptide) works in two different ways. It leads to inflammation and dilates the blood vessels right at the release point of the nerve cells, for example in the meninges, which can trigger migraine attacks. However, it has a completely different effect on the heart, as has now been discovered by a team of researchers at the University of Zurich.

26 Nov 2019

Industry executives reveal how profits drive rising prices for MS drugs

U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year.

26 Nov 2019

FDA-approved drug to prevent organ rejection may slow skin aging

The search for youthfulness typically turns to lotions, supplements, serums and diets, but there may soon be a new option joining the fray.

25 Nov 2019

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

On Nov. 21, 2019, the U.S. Food and Drug Administration approved the use of the drug acalabrutinib for first-line therapy in chronic lymphocytic leukemia and small cell lymphoma.

22 Nov 2019

Higher antibiotic exposure linked to increased risk of Parkinson's disease

Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson's disease according to a recently published study by researchers form the Helsinki University Hospital, Finland.

22 Nov 2019

Decreasing inappropriate antibiotic use is key strategy to control drug resistance

Antibiotic resistance is a larger public health threat than most people realize. And, the Centers for Disease Control and Prevention reports about half of all antibiotics in outpatient settings are incorrectly prescribed.

22 Nov 2019

New targeted treatment for insomnia has fewer side effects

Insomnia is one of the most common sleep disorders, and is most commonly treated with hypnotics. However, hypnotics have motor and cognitive side effects.

22 Nov 2019

Software tool can predict how drugs can be combined to create effective treatments

With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs--including unlikely candidates--can be combined in new ways to create more effective treatments.

22 Nov 2019

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

As the nation struggles with a persistent epidemic of opioid addiction, the University of Colorado Anschutz Medical Campus is taking a critical step that will allow its graduates to better treat patients and save lives.

21 Nov 2019

Anti-epileptic drugs linked to increase in patients' risk of suicide

Three of the most common forms of anti-epileptic drugs in Denmark is associated with increase in patients' risk of suicide. However, the risk is low and should be seen in conjunction with the many beneficial effects of the medicines.

21 Nov 2019

Statin use may reduce risk of developing lethal prostate cancer

New research led by Queen's University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.

21 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

New California law may expand use of HIV prevention drugs, with caveats

Kellen Willhite was 24 when he learned he'd been exposed to HIV. What followed was, as he describes it, a second trauma: trying to obtain the drugs that could save him before it was too late.

20 Nov 2019

New drug 'ubrogepant' may work for migraine

A new study published in the November 19, 2019 issue of JAMA shows that a newly developed small molecule drug called ubrogepant may successfully fight migraine at doses of 25 and 50 mg, with pain relief at 2 hours with both doses, while the most troublesome symptom of migraine was held off at 2 hours post-dose with the 50 mg dose. This may help millions of migraine patients to achieve pain relief and function better.

19 Nov 2019

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

The University of Barcelona and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer.

19 Nov 2019

Pharmaceutical News

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

Some antiarrhythmic medications for AFib less effective in obese patients

Geospatial model helps compare costs of different anticoagulant therapies

FDA-approved anti-inflammatory drug delays onset of ALS in mice

Giving a shot of ketamine could help heavy drinkers reduce alcohol intake

Innovative migraine prophylaxis could endanger people with chronic high blood pressure

Industry executives reveal how profits drive rising prices for MS drugs

FDA-approved drug to prevent organ rejection may slow skin aging

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

Higher antibiotic exposure linked to increased risk of Parkinson's disease

Decreasing inappropriate antibiotic use is key strategy to control drug resistance

New targeted treatment for insomnia has fewer side effects

Software tool can predict how drugs can be combined to create effective treatments

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

Anti-epileptic drugs linked to increase in patients' risk of suicide

Statin use may reduce risk of developing lethal prostate cancer

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New California law may expand use of HIV prevention drugs, with caveats

New drug 'ubrogepant' may work for migraine

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Latest News